C. diff. Spores and More

Join our guests, Paul Feuerstadt, MD, FACG, and Mena Boules, MD join us

to discuss Esophagitis and Chronic Idiopathic Constipation.

Eosinophilic gastroenteritis (EGE) represents one member within the spectrum of diseases collectively referred to as eosinophilic gastrointestinal disorders (EGIDs), which includes eosinophilic esophagitis (EoE), gastritis, enteritis, and colitis. Doctors Feuerstadt and Boules will discuss how some patients present with EGID limited to the stomach (eosinophilic gastritis, EG) or duodenum (eosinophilic duodenitis, ED, EoE, and EGE are closely related disease entities. Our guest Physicians will discuss the diagnosis of Esophagitis, EGE, EoE, Chronic Idiopathic Constipation treatments, and the management of these Digestive Health topics.

Join us with our two guests: Edmond A. Hooker, MD, DrPH, and Bruce Rippe, CEO Trinity Guardion as we discuss the Three Cleaning and Disinfection Mistakes that Put Patients At Risk Both Dr. Hooker and Bruce Rippe concentrate on patient safety and infection prevention in the healthcare industry. Trinity Guardion is a recipient of the C Diff Foundation's Infection Prevention Making a Difference Award. Their dedication focuses and elevates the importance of patient safety by raising the bar through the research and education on hospital/healthcare patient bed mattresses. The clinically proven hospital bed protection barrier prevents the spreading of infections. The Trinity Guardion organization is a leading trailblazer in patient safety and proven reductions in Healthcare-associated infections (HAI's) especially C. difficile infections. Tune in as we discuss HAI's, Disinfecting, Patient Safety, and the cleaning/disinfection mistakes that put patients at risk.

Join us with our guest, Barbara DeBaun, RN, MSN, CIC.

Barbara DeBaun has over 40 years of experience in the field of infection prevention and quality improvement.

We will be discussing Better Blood Culture Tests Equal

Better Patient Care, Fewer Antibiotics, and Less New Diagnosis of C. difficile.

Barbara DeBaun will be providing key points on Laboratory Stewardship,

Blood Culture gold standards, Venipuncture Technique to reduce contamination,

Peer-Reviewed studies and the technology being used outside of venipuncture.

Proper technique, reducing contaminated blood cultures, increase accurate

results, equals better patient care, fewer antibiotics, resulting in fewer newly

diagnosed cases of a C. difficile infection.

Join us with our guests from Seres Therapeutics as they discuss the latest news

on SER-109 and positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C. difficile infection (CDI). The study results were equally compelling when characterized by the alternative metric of sustained clinical response, where 88.9% of patients in the SER-109 arm achieved this objective. The study’s efficacy results exceeded the statistical threshold previously provided in consultation with the U.S. Food and Drug Administration (FDA) that could allow this single clinical study to fulfill efficacy requirements for a Biologics License Application (BLA). The SER-109 safety results were favorable, with an adverse event profile comparable to placebo. Listen in and learn more from the leading topic experts.

Join us with our guest, Dr. Anthony Gerlach, PharmD, as we discuss the role of the pharmacist focusing on clinical pharmacist or rounding pharmacist. He will also discuss how clinical pharmacists are involved in the treatment and prevention of

C. diff. infections.

Join us with our guest, Dr. Anthony Gerlach, PharmD, as we discuss the role of the pharmacist focusing on clinical pharmacist or rounding pharmacist. He will also discuss how clinical pharmacists are involved in the treatment and prevention of

C. diff. infections.

Join us with Guest; Mrs. Courtney Jones as we discuss we can cover the microbiome & C. diff (my area of knowledge), the importance of clinical trials in general, and how we as an industry are navigating the pandemic as other diseases don’t just “wait” for it to be over. Courtney will be discussing the human gut microbiome along with the C. diff. infection, recurrences, and major topics of both. Bring your tablet and prepare to take notes on these important topics.

Join us with Guest; Mrs. Courtney Jones as we discuss we can cover the microbiome & C. diff (my area of knowledge), the importance of clinical trials in general, and how we as an industry are navigating the pandemic as other diseases don’t just “wait” for it to be over. Courtney will be discussing the human gut microbiome along with the C. diff. infection, recurrences, and major topics of both. Bring your tablet and prepare to take notes on these important topics.

Join us with our guests from Seres Therapeutics as they discuss the latest news

on SER-109 and positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C. difficile infection (CDI). The study results were equally compelling when characterized by the alternative metric of sustained clinical response, where 88.9% of patients in the SER-109 arm achieved this objective. The study’s efficacy results exceeded the statistical threshold previously provided in consultation with the U.S. Food and Drug Administration (FDA) that could allow this single clinical study to fulfill efficacy requirements for a Biologics License Application (BLA). The SER-109 safety results were favorable, with an adverse event profile comparable to placebo. Listen in and learn more from the leading topic experts.

Join us with our Host, Nancy Caralla and

our special Guest Host, Kevin Hersh, International Health Coach who will discuss ways to move forward past a long-term illness, and a long-term negative mind-set. Taking a moment to reflect, step back, evaluate, and look for the assets and positives in moving forward. Learn how to let the past go and embrace the new opportunities each day delivers. It takes strength, will, and the determination to step into the light and out of the darkness of the illness that paralyzes a healthy individual. Join us and take a step in a new direction.